Literature DB >> 34125200

The Nursing Home Older Adult Gut Microbiome Composition Shows Time-dependent Dysbiosis and Is Influenced by Medication Exposures, Age, Environment, and Frailty.

John P Haran1,2, Abigail Zeamer2,3, Doyle V Ward2,3, Protiva Dutta1, Vanni Bucci2,3, Beth A McCormick2,3.   

Abstract

Older adults in nursing homes (NHs) have increased frailty, medication, and antimicrobial exposures, all factors that are known to affect the composition of gut microbiota. Our objective was to define which factors have the greatest association with the NH resident gut microbiota, explore patterns of dysbiosis and compositional changes in gut microbiota over time in this environment. We collected serial stool samples from NH residents. Residents were assessed using the Mini Nutritional Assessment tool and Clinical Frailty Scale. Bacterial composition of resident stool samples was determined by metagenomic sequencing. We used mixed-effect random forest modeling to identify clinical covariates that associate with microbiota. We enrolled and followed 166 residents from 5 NHs collecting 512 stool samples and following 15 residents for > 1 year. Medications, particularly psychoactive and antihypertensive medications, had the greatest effect on the microbiota. Age and frailty also contributed, and were associated with increased and decreased diversity, respectively. The microbiota of residents who had lived in the NH for > 1 year were enriched in inflammatory and pathogenic species and reduced in anti-inflammatory and symbiotic species. We observed intraindividual stability of the microbiome among older adults who had lived in the NH already for >1 year followed with sample collections 1 year apart. Older adult NH gut microbiome is heavily influenced by medications, age, and frailty. This microbiome is influenced by the length of NH residency with dysbiosis becoming evident at 12 months, however, after this point there is demonstrated relative stability over time.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Antibiotics; Frailty; Gut microbiome; Medications; Nursing home; Residents

Mesh:

Year:  2021        PMID: 34125200      PMCID: PMC8514073          DOI: 10.1093/gerona/glab167

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.591


  50 in total

1.  The influence of non-steroidal anti-inflammatory drugs on the gut microbiome.

Authors:  M A M Rogers; D M Aronoff
Journal:  Clin Microbiol Infect       Date:  2015-10-16       Impact factor: 8.067

Review 2.  Frailty and the gut.

Authors:  Antonio Di Sabatino; Marco Vincenzo Lenti; Lisa Cammalleri; Gino Roberto Corazza; Alberto Pilotto
Journal:  Dig Liver Dis       Date:  2018-03-16       Impact factor: 4.088

Review 3.  Obesity, diabetes, and the gut microbiome: an updated review.

Authors:  Tahli Singer-Englar; Gillian Barlow; Ruchi Mathur
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2018-11-13       Impact factor: 3.869

Review 4.  Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis.

Authors:  Gotaro Kojima
Journal:  J Am Med Dir Assoc       Date:  2015-08-06       Impact factor: 4.669

5.  Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work.

Authors:  Steven R Austin; Yu-Ning Wong; Robert G Uzzo; J Robert Beck; Brian L Egleston
Journal:  Med Care       Date:  2015-09       Impact factor: 2.983

Review 6.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

7.  The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation.

Authors:  Christina Engels; Hans-Joachim Ruscheweyh; Niko Beerenwinkel; Christophe Lacroix; Clarissa Schwab
Journal:  Front Microbiol       Date:  2016-05-19       Impact factor: 5.640

8.  Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia.

Authors:  Jiyeon Kim; Heetae Lee; Jinho An; Youngcheon Song; Chong-Kil Lee; Kyungjae Kim; Hyunseok Kong
Journal:  Front Microbiol       Date:  2019-09-04       Impact factor: 5.640

Review 9.  What is polypharmacy? A systematic review of definitions.

Authors:  Nashwa Masnoon; Sepehr Shakib; Lisa Kalisch-Ellett; Gillian E Caughey
Journal:  BMC Geriatr       Date:  2017-10-10       Impact factor: 4.070

10.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.